Tech Company Financing Transactions

NeuroTronik Funding Round

On 4/19/2017, NeuroTronik received $23.1 million in Series B investment from Boston Scientific Corporation, Hatteras Venture Partners and Mountain Group Capital.

Transaction Overview

Company Name
Announced On
4/19/2017
Transaction Type
Venture Equity
Amount
$23,100,000
Round
Series B
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1414 Raleigh Rd. 415
Chapel Hill, NC 27517
USA
Website
Email Address
Not Recorded
Overview
The company's Nuuromodulation System aims to shorten hospital stays and reduce the need of patients to return to the hospital a few weeks later.
Profile
NeuroTronik LinkedIn Company Profile
Social Media
NeuroTronik Company Twitter Account
Company News
NeuroTronik News
Facebook
NeuroTronik on Facebook
YouTube
NeuroTronik on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Frederick McCoy
  Frederick McCoy LinkedIn Profile  Frederick McCoy Twitter Account  Frederick McCoy News  Frederick McCoy on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/19/2017: V5 Systems venture capital transaction
Next: 4/19/2017: TurboTenant venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary